| Year |
Citation |
Score |
| 2013 |
Lee EK, Hu C, Bhargava R, Ponnusamy R, Park H, Novicoff S, Rozengurt N, Marescau B, De Deyn P, Stout D, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS. AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. Gene Therapy. 20: 785-96. PMID 23388701 DOI: 10.1038/Gt.2012.99 |
0.312 |
|
| 2010 |
Deignan JL, De Deyn PP, Cederbaum SD, Fuchshuber A, Roth B, Gsell W, Marescau B. Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia. Molecular Genetics and Metabolism. 100: S31-6. PMID 20176499 DOI: 10.1016/J.Ymgme.2010.01.012 |
0.366 |
|
| 2009 |
Eloot S, van Biesen W, Dhondt A, de Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R. Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 24: 2225-32. PMID 19225018 DOI: 10.1093/Ndt/Gfp059 |
0.368 |
|
| 2008 |
Levillain O, Marescau B, Possemiers I, De Deyn PP. Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats. Metabolism: Clinical and Experimental. 57: 802-10. PMID 18502263 DOI: 10.1016/J.Metabol.2008.01.025 |
0.382 |
|
| 2008 |
Taes YE, Marescau B, De Vriese A, De Deyn PP, Schepers E, Vanholder R, Delanghe JR. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 23: 1330-5. PMID 18048424 DOI: 10.1093/Ndt/Gfm793 |
0.415 |
|
| 2008 |
Deignan JL, Marescau B, Livesay JC, Iyer RK, De Deyn PP, Cederbaum SD, Grody WW. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. Molecular Genetics and Metabolism. 93: 172-8. PMID 17997338 DOI: 10.1016/J.Ymgme.2007.09.016 |
0.41 |
|
| 2007 |
Eloot S, Torremans A, De Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R. Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 50: 279-88. PMID 17660029 DOI: 10.1053/J.Ajkd.2007.05.009 |
0.75 |
|
| 2006 |
Torremans A, Marescau B, Kränzlin B, Gretz N, Billiouw JM, Vanholder R, De Smet R, Bouwman K, Brouns R, De Deyn PP. Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition. Kidney International. 69: 2003-12. PMID 16641922 DOI: 10.1038/Sj.Ki.5000443 |
0.755 |
|
| 2005 |
Van Dam D, Marescau B, Cremers T, Mulder J, Engelborghs S, De Deyn PP. Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain. Amino Acids. 28: 377-87. PMID 15889219 DOI: 10.1007/S00726-005-0208-7 |
0.335 |
|
| 2005 |
Torremans A, Marescau B, Possemiers I, Van Dam D, D'Hooge R, Isbrandt D, De Deyn PP. Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency. Journal of the Neurological Sciences. 231: 49-55. PMID 15792821 DOI: 10.1016/J.Jns.2004.12.014 |
0.744 |
|
| 2005 |
Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney International. 67: 1566-75. PMID 15780113 DOI: 10.1111/j.1523-1755.2005.00238.x |
0.762 |
|
| 2005 |
Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochemistry International. 46: 409-22. PMID 15737439 DOI: 10.1016/J.Neuint.2004.11.005 |
0.347 |
|
| 2005 |
Torremans A, Marescau B, Van Dam D, Van Ginneken C, Van Meir F, Van Bogaert PP, D'Hooge R, de Vente J, De Deyn PP. GSA: behavioral, histological, electrophysiological and neurochemical effects. Physiology & Behavior. 84: 251-64. PMID 15708777 DOI: 10.1016/J.Physbeh.2004.12.001 |
0.747 |
|
| 2005 |
Eloot S, Smet RD, Torremans A, Wachter DD, Marescau B, Deyn PPD, Verdonck P, Vanholder R. Urea kinetics are not representative for the behavior of other small and water-soluble compounds Hemodialysis International. 9: 80-80. DOI: 10.1111/J.1492-7535.2005.1121Ab.X |
0.745 |
|
| 2005 |
Eloot S, Smet RD, Torremans A, Marescau B, Deyn PD, Verdonck P, Vanholder R. Inadequate representativity of urea for the kinetics of other water-soluble compounds Asaio Journal. 51: 59. DOI: 10.1097/00002480-200503000-00229 |
0.741 |
|
| 2004 |
Derave W, Marescau B, Vanden Eede E, Eijnde BO, De Deyn PP, Hespel P. Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans. Journal of Applied Physiology (Bethesda, Md. : 1985). 97: 852-7. PMID 15107411 DOI: 10.1152/Japplphysiol.00206.2004 |
0.38 |
|
| 2004 |
Torremans A, D'Hooge R, Van de Vijver G, Marescau B, Vanholder R, Lameire N, De Deyn PP, Van Bogaert PP. Effect of NaCN on currents evoked by uremic retention solutes in dissociated mouse neurons. Brain Research. 1008: 107-12. PMID 15081387 DOI: 10.1016/J.Brainres.2004.02.021 |
0.737 |
|
| 2004 |
Schmidt A, Marescau B, Boehm EA, Renema WK, Peco R, Das A, Steinfeld R, Chan S, Wallis J, Davidoff M, Ullrich K, Waldschütz R, Heerschap A, De Deyn PP, Neubauer S, et al. Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Human Molecular Genetics. 13: 905-21. PMID 15028668 DOI: 10.1093/Hmg/Ddh112 |
0.35 |
|
| 2003 |
Torremans A, Marescau B, Vanholder R, De Smet R, Billiouw JM, De Deyn PP. The low nanomolar levels of N G-monomethylarginine in serum and urine of patients with chronic renal insufficiency are not significantly different from control levels. Amino Acids. 24: 375-81. PMID 12768499 DOI: 10.1007/S00726-002-0346-0 |
0.747 |
|
| 2003 |
D'Hooge R, Van de Vijver G, Van Bogaert PP, Marescau B, Vanholder R, De Deyn PP. Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins. Kidney International. 63: 1764-75. PMID 12675852 DOI: 10.1046/J.1523-1755.2003.00912.X |
0.34 |
|
| 2002 |
Levillain O, Marescau B, Possemiers I, De Deyn P. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney. PflüGers Archiv : European Journal of Physiology. 444: 143-52. PMID 11976926 DOI: 10.1007/S00424-002-0787-Z |
0.381 |
|
| 2001 |
Al Banchaabouchi M, Marescau B, D'Hooge R, De Deyn PP. The effect of high protein diet on urea and guanidino compound levels in renal insufficient mice. Amino Acids. 21: 401-15. PMID 11858699 DOI: 10.1007/S007260170005 |
0.367 |
|
| 2001 |
Al Banchaabouchi M, Marescau B, Van Marck E, D'hooge R, De Deyn PP. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice. Metabolism: Clinical and Experimental. 50: 1418-25. PMID 11735086 DOI: 10.1053/Meta.2001.26763 |
0.415 |
|
| 2001 |
de Jonge WJ, Marescau B, D'Hooge R, De Deyn PP, Hallemeesch MM, Deutz NE, Ruijter JM, Lamers WH. Overexpression of arginase alters circulating and tissue amino acids and guanidino compounds and affects neuromotor behavior in mice. The Journal of Nutrition. 131: 2732-40. PMID 11584097 DOI: 10.1093/Jn/131.10.2732 |
0.396 |
|
| 2001 |
Levillain O, Marescau B, Possemiers I, Banchaabouchi M, De Deyn P. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: A time course study Pflugers Archiv European Journal of Physiology. 442: 558-569. PMID 11510889 DOI: 10.1007/S004240100581 |
0.4 |
|
| 2001 |
De Deyn PP, D'Hooge R, Van Bogaert PP, Marescau B. Endogenous guanidino compounds as uremic neurotoxins. Kidney International. Supplement. 78: S77-83. PMID 11168988 DOI: 10.1046/J.1523-1755.2001.59780077.X |
0.399 |
|
| 2000 |
Al Banchaabouchi M, Marescau B, D'Hooge R, Engelborghs S, De Deyn PP. Consequences of renal mass reduction on amino acid and biogenic amine levels in nephrectomized mice. Amino Acids. 18: 265-77. PMID 10901623 DOI: 10.1007/S007260050023 |
0.373 |
|
| 2000 |
Al Banchaabouchi M, Marescau B, Possemiers I, D'Hooge R, Levillain O, De Deyn PP. NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency. Pflã¼Gers Archiv : European Journal of Physiology. 439: 524-31. PMID 10764210 DOI: 10.1007/S004240050973 |
0.398 |
|
| 1999 |
Al Banchaabouchi M, D'Hooge R, Marescau B, De Deyn PP. Behavioural deficits during the acute phase of mild renal failure in mice. Metabolic Brain Disease. 14: 173-87. PMID 10646693 DOI: 10.1023/A:1020662725476 |
0.313 |
|
| 1998 |
Schulze A, Mayatepek E, Frank S, Marescau B, De Deyn PP, Bachert P. Disturbed metabolism of guanidino compounds characterized by elevated excretion of β-guanidinopropionic acid and γ-guanidinobutyric acid - An effect of vigabatrin treatment? Journal of Inherited Metabolic Disease. 21: 268-271. PMID 9686372 DOI: 10.1023/A:1005376307471 |
0.322 |
|
| 1998 |
Al Banchaabouchi M, Marescau B, D'Hooge R, Van Marck E, Van Daele A, Levillain O, De Deyn PP. Biochemical and histopathological changes in nephrectomized mice. Metabolism: Clinical and Experimental. 47: 355-61. PMID 9500577 DOI: 10.1016/S0026-0495(98)90271-2 |
0.366 |
|
| 1997 |
Schulze A, Hess T, Wevers R, Mayatepek E, Bachert P, Marescau B, Knopp MV, De Deyn PP, Bremer HJ, Rating D. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. The Journal of Pediatrics. 131: 626-31. PMID 9386672 DOI: 10.1016/S0022-3476(97)70075-1 |
0.377 |
|
| 1997 |
Verhelst J, Berwaerts J, Marescau B, Abs R, Neels H, Mahler C, De Deyn PP. Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction Metabolism: Clinical and Experimental. 46: 1063-1067. PMID 9284897 DOI: 10.1016/S0026-0495(97)90279-1 |
0.352 |
|
| 1997 |
Marescau B, Nagels G, Possemiers I, De Broe ME, Becaus I, Billiouw JM, Lornoy W, De Deyn PP. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency Metabolism: Clinical and Experimental. 46: 1024-1031. PMID 9284891 DOI: 10.1016/S0026-0495(97)90273-0 |
0.42 |
|
| 1997 |
Deshmukh DR, Ghole VS, Marescau B, De Deyn PP. Effect of endotoxemia on plasma and tissue levels of nitric oxide metabolites and guanidino compounds Archives of Physiology and Biochemistry. 105: 32-37. PMID 9224544 DOI: 10.1076/Apab.105.1.32.13144 |
0.355 |
|
| 1996 |
Gentens P, De Deyn PP, D'Hooge R, Pei H, Tassignon MJ, Van Dromme S, Marescau B. Rabbit model simulating transient hyperglycinemia following transurethral prostatectomy. Amino Acids. 11: 43-53. PMID 24178637 DOI: 10.1007/Bf00805720 |
0.332 |
|
| 1996 |
Ratnakumari L, Qureshi IA, Butterworth RF, Marescau B, De Deyn PP. Arginine-related guanidino compounds and nitric oxide synthase in the brain of ornithine transcarbamylase deficient spf mutant mouse: effect of metabolic arginine deficiency. Neuroscience Letters. 215: 153-6. PMID 8899736 DOI: 10.1016/0304-3940(96)12975-X |
0.354 |
|
| 1995 |
De Deyn PP, Marescau B, D'Hooge R, Possemiers I, Nagler J, Mahler C. Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochemistry International. 27: 227-37. PMID 8520461 DOI: 10.1016/0197-0186(95)00041-6 |
0.38 |
|
| 1995 |
De Deyn PP, Robitaille P, Vanasse M, Qureshi IA, Marescau B. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations Nephron. 69: 411-417. PMID 7777105 DOI: 10.1159/000188511 |
0.353 |
|
| 1995 |
Marescau B, De Deyn PP, Holvoet J, Possemiers I, Nagels G, Saxena V, Mahler C. Guanidino compounds in serum and urine of cirrhotic patients Metabolism. 44: 584-588. PMID 7752905 DOI: 10.1016/0026-0495(95)90114-0 |
0.351 |
|
| 1994 |
D'Hooge R, Pei YQ, Marescau B, De Deyn PP. Ontogenetic differences in convulsive action and cerebral uptake of uremic guanidino compounds in juvenile mice. Neurochemistry International. 24: 215-20. PMID 8025530 DOI: 10.1016/0197-0186(94)90078-7 |
0.334 |
|
| 1993 |
Henning RH, Wierda JMKH, Scaf AHJ, Marescau B, De Deyn PP, Agoston S. Increased Sensitivity to Vecuronium in Patients with Chronic Renal Failure Drug Investigation. 5: 98-107. DOI: 10.1007/Bf03259580 |
0.396 |
|
| 1992 |
Marescau B, Deshmukh DR, Kockx M, Possemiers I, Qureshi IA, Wiechert P, De Deyn PP. Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals Metabolism. 41: 526-532. PMID 1588833 DOI: 10.1016/0026-0495(92)90213-T |
0.423 |
|
| 1992 |
Marescau B, De Deyn PP, Qureshi IA, De Broe ME, Antonozzi I, Cederbaum SD, Cerone R, Chamoles N, Gatti R, Kang SS, Lambert M, Possemiers I, Snyderman SE, Yoshino M. The pathobiochemistry of uremia and hyperargininemia further demonstrates a metabolic relationship between urea and guanidinosuccinic acid Metabolism. 41: 1021-1024. PMID 1518417 DOI: 10.1016/0026-0495(92)90131-S |
0.329 |
|
| 1992 |
D'Hooge R, Pei YQ, Marescau B, De Deyn PP. Behavioral toxicity of guanidinosuccinic acid in adult and young mice. Toxicology Letters. 64: 773-7. PMID 1471235 DOI: 10.1016/0378-4274(92)90261-H |
0.318 |
|
| 1992 |
D'Hooge R, Pei YQ, Marescau B, De Deyn PP. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice. Journal of the Neurological Sciences. 112: 96-105. PMID 1469446 DOI: 10.1016/0022-510X(92)90138-B |
0.308 |
|
| 1991 |
Meert KL, Deshmukh DR, Marescau B, De Deyn PP, Sarnaik AP. Effect of ammonium acetate-induced hyperammonemia on metabolism of guanidino compounds Biochemical Medicine and Metabolic Biology. 46: 208-214. PMID 1782011 DOI: 10.1016/0885-4505(91)90068-V |
0.42 |
|
| 1991 |
De Deyn PP, Marescau B, Macdonald RL. Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture Epilepsy Research. 8: 134-141. PMID 1712285 DOI: 10.1016/0920-1211(91)90081-P |
0.32 |
|
| 1990 |
De Deyn PP, Marescau B, Swartz RD, Hogaerth R, Possemiers I, Lowenthal A. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis Nephron. 54: 307-312. PMID 2325795 DOI: 10.1159/000185885 |
0.436 |
|
| 1990 |
Marescau B, De Deyn PP, Lowenthal A, Qureshi IA, Antonozzi I, Bachmann C, Cederbaum SD, Cerone R, Chamoles N, Colombo JP. Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy. Pediatric Research. 27: 297-303. PMID 1690873 DOI: 10.1203/00006450-199003000-00020 |
0.393 |
|
| 1987 |
De Deyn PP, Marescau B, Cuykens JJ, Van Gorp L, Lowenthal A, De Potter WP. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency Clinica Chimica Acta. 167: 81-88. PMID 3665089 DOI: 10.1016/0009-8981(87)90088-X |
0.409 |
|
| 1987 |
de Deyn P, Marescau B, Lornoy W, Becaus I, Van Leuven I, Van Gorp L, Lowenthal A. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis Nephron. 45: 291-295. PMID 3587469 DOI: 10.1159/000184166 |
0.428 |
|
| 1986 |
Marescau B, De Deyn P, Wiechert P, Van Gorp L, Lowenthal A. Comparative Study of Guanidino Compounds in Serum and Brain of Mouse, Rat, Rabbit, and Man Journal of Neurochemistry. 46: 717-720. PMID 3950603 DOI: 10.1111/J.1471-4159.1986.Tb13030.X |
0.372 |
|
| 1986 |
De Deyn P, Marescau B, Lornoy W, Becaus I, Lowenthal A. Guanidino compounds in uraemic dialysed patients Clinica Chimica Acta. 157: 143-150. PMID 3719996 DOI: 10.1016/0009-8981(86)90220-2 |
0.434 |
|
| 1986 |
Marescau B, de Deyn P, van Gorp L, Lowenthal A. Purification procedure for some urinary guanidino compounds Journal of Chromatography B: Biomedical Sciences and Applications. 377: 334-338. PMID 3711224 DOI: 10.1016/S0378-4347(00)80789-6 |
0.313 |
|
| 1981 |
Marescau B, Lowenthal A, Esmans E, Luyten Y, Alderweiereldt F, Terheggen HG. Isolation and identification of some guanidino compounds in the urine of patients with hyperargininaemia by liquid chromatography, thin-layer chromatography and gas chromatography-mass spectrometry Journal of Chromatography B: Biomedical Sciences and Applications. 224: 185-195. DOI: 10.1016/S0378-4347(00)80156-5 |
0.35 |
|
| 1979 |
Marescau B, Pintens J, Lowenthal A, Terheggen HG. Excretion of α-keto-δ-guanidinovaleric acid and its cyclic form in patients with hyperargininemiA Clinica Chimica Acta. 98: 35-38. PMID 498528 DOI: 10.1016/0009-8981(79)90162-1 |
0.337 |
|
| Show low-probability matches. |